1-3 of 3
Annamaria Pellecchia
Close
Sort by
Journal Articles

Complement-mediated oxidative damage of red cells impairs response to eculizumab in a G6PD-deficient patient with PNH

Michela Sica, Annamaria Pellecchia, Maria De Angioletti, Giovanni Caocci, Caterina Nannelli, Giorgio La Nasa, Lucio Luzzatto, Rosario Notaro
Journal: Blood
Blood (2020) 136 (26): 3082–3085.
https://doi.org/10.1182/blood.2020007780
Published: 2020
Includes: Supplemental data
Journal Articles

Complement Activation in Paroxysmal Nocturnal Hemoglobinuria (PNH) Causes Oxidative Damage Which May Affect Response to Eculizumab

Michela Sica, PhD, Annamaria Pellecchia, PhD, Margherita Berardi, BS, Lucia Gargiulo, PhD, Tolulase A Olutogun, MD, Giovanni Caocci, MD, Giorgio La Nasa, MD, Maria De Angioletti, PhD, Lucio Luzzatto, MD FRCP, FRCPath, Rosario Notaro, MD
Journal: Blood
Blood (2014) 124 (21): 4397.
https://doi.org/10.1182/blood.V124.21.4397.4397
Published: 2014
Journal Articles

Role of the Somatic Mutation Rate in Patients with Classical Myeloproliferative Neoplasms (MPN) with and without Other Neoplasms

Margherita Berardi, BS, Tommaso Rondelli, BS, Maria Chiara Susini, MD, Annamaria Pellecchia, BS, Elisabetta Antonioli, MD, Luca Boni, MD, Lucio Luzzatto, MD, FRCP, FRCPath, Alessandro M. Vannucchi, MD, Rosario Notaro, MD
Journal: Blood
Blood (2012) 120 (21): 5055.
https://doi.org/10.1182/blood.V120.21.5055.5055
Published: 2012